AGP Executive Report
Last update: 5 hours agoMedical Cannabis Business: Althea Group exits its UK and Ireland clinic operations by selling to Montu, a retreat from costly offshore expansion as the company refocuses on the home market. Policy & Tax: Yale’s Budget Lab floats a federal cannabis excise tax based on THC potency, projecting $57.9B over 10 years (or $111.3B if all states legalize), though potency labels are often disputed. Research & Health: A new Oregon psilocybin study reports most participants saw improvements in depression and anxiety, with uncommon adverse effects—another sign regulators are building “guardrails” for psychedelics. Vape Safety: Ireland’s HSE urges tighter vape regulation after lab testing found high-risk synthetic cannabinoids and mislabeling across shop and online products. Cannabis & Crime: Greek police dismantle a cannabis smuggling network using recyclable paper shipments as cover, seizing raw cannabis and arresting suspects. Public Health & Community: Nigeria’s Cerba Lancet runs free hepatitis B screening in Mushin, highlighting prevention and early detection needs alongside broader wellness efforts. Industry & Markets: Tilray shares jump amid broader risk-asset lift, but the stock remains deeply down year-to-date.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
